Moody’s officials believe the supercommittee will target four main areas within healthcare: Medicare cost-sharing for seniors, payments to healthcare providers, prescription drug costs and Medicaid spending.
This would most likely impact both non-profit and for-profit hospital negatively, according to the release. Currently, the federal government reimburses providers roughly 70 percent of bad debts involving Medicare beneficiaries who don’t pay co-insurance and deductible amounts exempt from Medicare. Lisa Goldstein, associate managing director in Moody’s non-profit hospital division, said a supercommittee deal could result in a 25-45 percent drop.
Drug companies would most likely see an increase in rebates toward the government, which could result in a 2-7 percent hit to their revenues.
Related Articles on the Supercommittee:
Supercommittee Expected to Maintain Healthcare Reform Funding
Supercommittee Democrats Propose $350B in Savings Through Medicare Reform
House Members Urge Supercommittee to Protect Critical Access Hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
